Did the Russian vaccine trial show antibodies in the bodies of all the people?

Moscow, September 5, 2020, Saturday

Russia claimed to have developed the world's first Covid-19 vaccine last August to combat the growing Corona virus epidemic. The news was reassuring as millions of people fearing a coronary heart disease were waiting for a vaccine or antidepressant. Especially. Russia's vaccine research has been controversial in the West and in the United States. Russia's study data on the corona vaccine was considered unsafe, effective and insufficient.

However, Russia's Corona vaccine, Sputnik V, has been tested in humans without any adverse effects, according to a study published in The Lancet Journal on Friday. .

In the initial phase of the vaccination, a total of 76 people were tested and the vaccine was found to be safe after 42 days. The vaccine showed that all humans developed antibodies within 21 days. The researchers found that the results of the second phase were 28 days after the formation of T cells (killer T cells). The original purpose of this vaccine was to develop antibodies and T cells to protect the body from coronavirus attacks.

Denis Logunov, lead author of the scientific study at the National Research Center for Microbiology Gamelia in Russia, said that when the anti-virus vaccine enters the body, an invasive protein that kills covid-19 is produced. So that the immune system seems to recognize the corona and destroy it. Tests on the Sputnik vaccine were performed in two Russian hospitals involving citizens between the ages of 18 and 60.

According to a researcher at the Johns Hopkins Bloomberg School of Public Health in the United States, the results of the vaccine test have been encouraging, but on a much smaller scale. The authors of the study emphasized the need for further study to prove the effectiveness of vaccines in different populations and communities. The third phase of testing of the vaccine was approved on August 26, according to Prof. Alexander Gintsberg of Russia's Research Center. In which 40000 volunteers and a group of different ages were involved.